Access count of this item: 439

Files in This Item:
File Description SizeFormat 
31_921.pdf12.9 MBAdobe PDFView/Open
Title: 経皮的超音波破砕による腎結石の治療経験
Other Titles: Percutaneous ultrasonic nepholithotripsy
Authors: 川村, 寿一  KAKEN_name
東, 義人  KAKEN_name
西村, 昌則  KAKEN_name
木原, 裕次  KAKEN_name
田中, 寛郷  KAKEN_name
武縄, 淳  KAKEN_name
野々村, 光生  KAKEN_name
飛田, 収一  KAKEN_name
大石, 賢二  KAKEN_name
吉田, 修  KAKEN_name
Author's alias: KAWAMURA, Juichi
HIGASHI, Yoshihito
NISHIMURA, Masanori
KIHARA, Yuji
TANAKA, Hirosato
TAKENAWA, Atsushi
NONOMURA, Mitsuo
HIDA, Shuichi
OISHI, Kenji
YOSHIDA, Osamu
Keywords: Percutaneousu ltrasonic nephrolithotripsy
Renal calculi
Issue Date: Jun-1985
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 31
Issue: 6
Start page: 921
End page: 929
Abstract: 1984年3月~12月までに,32例の腎結石症例に対して,主として西独Wolf社製硬性鏡を使って経皮的超音波破砕をおこなった.1)臨床的に結石を除去しえた成功率は,78.1%(最近4ヵ月では91.3%)で,重篤な合併症はなく,破砕後数日,血尿がみられた.輸血を必要とした症例はなかった.2)本法の成功する鍵のひとつは,あらかじめ,一期的にしろ,二期的にしろ,よい位置に腎瘻を作ることである.3)超音波破砕・吸引装置を備えた硬性鏡のみならず,軟性鏡やいろいろの把持鉗子,ドルミアを駆使することにより,腎結石の90%以上は経皮的アプローチにより治療できる可能性が示された
Herein we report our experience of percutaneous ultrasonic lithotripsy on 32 renal calculus patients between March and December 1984. Renal calculus removal was successful in over 78.1% of the patients (91.3% for recent 4 months). All patients had bloody urine after tract dilatation and calculus removal, but this usually cleared in 24-48 hours. No patients have required blood transfusion. The major essential contribution responsible for the success of this technique was a nephrostomy placement made accessible to calculi. Percutaneous ultrasonic lithotripsy, when combined with adjuncts such as flexible nephroscopy and radiological stone manipulations using stone grasping forceps and Dormia basket catheter, is an effective treatment for renal calculi, with a success rate of over 90%.
URI: http://hdl.handle.net/2433/118523
PubMed ID: 4061210
Appears in Collections:Vol.31 No.6

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.